global therapeutic vaccines market is expected to reach usd 4820.26 million by 2021 with a cagr of...

3
According to the report Global Therapeutic Vaccines Market, published by Market Data Forecast, the Global Market is estimated at USD 1132.50 Million in 2015, and is poised to reach USD 4820.26 Million by 2020 with a CAGR of 33.6%. The vaccine Market is different from any other commodity market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. It is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context. For full report refer to http://www.marketdataforecast.com/market-reports/global- therapeutic-vaccines-market-71/ Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market. Free sample of the report is available at http://www.marketdataforecast.com/market- reports/global-therapeutic-vaccines-market-71/request-sample The Global Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, based on geography the global market is analysed under various regions namely, North America, Europe, Asia Pacific, Latin America and Middle-East & Africa. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region. Enquire more about the report http://www.marketdataforecast.com/market-reports/global- therapeutic-vaccines-market-71/inquire Global Therapeutic Vaccines Market segmented based on Type, geography as follows: By Disease Type Autoimmune Disease Vaccines Cancer Vaccines (Multikine, PR1 Peptide, TroVax and CYT004-MelQbG10) Neurological Disease Vaccines (ACC- 001, CAD 106, Parkinson's and Alzheimer's) Infectious Disease Vaccines (Hepatitis C, HIV/AIDS, and Others) Others Based on Geography

Upload: srikanth-sadineni

Post on 12-Apr-2017

5 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Global therapeutic vaccines market is expected to reach usd 4820.26 million by 2021 with a cagr of 33.6%

According to the report Global Therapeutic Vaccines Market, published by Market Data Forecast, the Global Market is estimated at USD 1132.50 Million in 2015, and is poised to reach USD 4820.26 Million by 2020 with a CAGR of 33.6%.

The vaccine Market is different from any other commodity market. Compared to the pharmaceutical

market it is relatively small, although growing at a fast rate. There are presently close to 120 new

vaccines in the pipeline of various multinational companies across the globe set to hit the market in

the next few years. It is rather concentrated on both supply and demand sides. It is highly regulated

and mostly dependent on public purchasers and donor policies. It has very distinct features which

increase the complexity of assessing and understanding pricing and procurement in their context.

For full report refer to http://www.marketdataforecast.com/market-reports/global-therapeutic-vaccines-market-71/

Increase in funding’s from government for vaccine development, rise in investments by the major

market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are

some of the factors that are propelling the market growth. However, massive capital expenditures

and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the

growth of the market.

Free sample of the report is available at http://www.marketdataforecast.com/market-

reports/global-therapeutic-vaccines-market-71/request-sample

The Global Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune

Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax,

CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease

Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis

C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, based on geography the global

market is analysed under various regions namely, North America, Europe, Asia Pacific, Latin America

and Middle-East & Africa. North America accounts for the large portion of revenue in the

therapeutic vaccine market. The growth of this market will be boosted owing to the presence of

advanced and active R&D establishments in the region.

Enquire more about the report http://www.marketdataforecast.com/market-reports/global-

therapeutic-vaccines-market-71/inquire

Global Therapeutic Vaccines Market segmented based on Type, geography as follows:

By Disease Type

Autoimmune Disease Vaccines

Cancer Vaccines (Multikine, PR1 Peptide, TroVax and CYT004-MelQbG10)

Neurological Disease Vaccines (ACC- 001, CAD 106, Parkinson's and Alzheimer's)

Infectious Disease Vaccines (Hepatitis C, HIV/AIDS, and Others)

Others

Based on Geography

Page 2: Global therapeutic vaccines market is expected to reach usd 4820.26 million by 2021 with a cagr of 33.6%

North America therapeutic vaccines Market Europe therapeutic vaccines Market

Asia-Pacific therapeutic vaccines Market

Latin America therapeutic vaccines Market

Middle East and Africa therapeutic vaccines Market

Some of the key players influencing the global preventive vaccine market are GlaxoSmithKline, plc.,

Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson

and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

Buy now https://www.marketdataforecast.com/cart/buy-now/global-therapeutic-vaccines-market-

71

The Therapeutic Vaccines Market study offers the following deliverables:

Global, Regional and country-level analysis and forecasts of the study market;

providing Insights on the major countries/regions in which this industry is blooming

and to also identify the regions that are still untapped

Segment-level analysis in terms of technology, component, and type along with

market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the

market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global

market; which includes broadly demographic, economics, and political, among other

macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an

Industry, using Porter’s five forces analysis for analysing the level of competition

and business strategy development

A comprehensive list of key market players along with their product portfolio,

current strategic interests, key financial information, legal issues, SWOT analysis and

analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations

in the field along with new product launches, comparative financial studies and

recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decision-

making personnel can rapidly become acquainted with background information,

concise analysis and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide

both individuals and organizations a strong financial foothold in the market

Page 3: Global therapeutic vaccines market is expected to reach usd 4820.26 million by 2021 with a cagr of 33.6%

Checkout related reports in the Therapeutic Market Category:

Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-

reports/global-anticoccidial-drugs-market-13/

Antifungal Drugs Market: http://www.marketdataforecast.com/market-reports/global-

anti-fungal-drugs-market-242/

Bladder Cancer Therapeutics Market: http://www.marketdataforecast.com/market-

reports/global-bladder-cancer-therapeutics-market-1149/

Preventive Vaccine market:

http://www.marketdataforecast.com/market-reports/global-preventive-vaccine-

market-160/

About Us:

Market Data Forecast is a firm working in the area of market research and business

intelligence. With rich experience in research across various business domains, we cater to

the needs of both individual and corporate clients. Our analyst team comprises expert

professionals in market research, who with their collective knowledge and skillset

dedicatedly serve clients from various industries and regions.

Contact: Abhishek Shukla Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: [email protected]

Visit Marketdata Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases